Inventor
LIU SHUANG
CN140 patents
⚠️ This page may combine multiple inventors who share the name “LIU SHUANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB PHARMA CO
12 patentsUS6537520B1Mar 25, 2003
Pharmaceuticals for the imaging of angiogenic disorders
BRISTOL MYERS SQUIBB PHARMA CO91 citations96
US6800273B2Oct 5, 2004
Pharmaceuticals for the imaging of angiogenic disorders
BRISTOL MYERS SQUIBB PHARMA CO46 citations95
US6776977B2Aug 17, 2004
Polypodal chelants for metallopharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO36 citations93
US6713042B2Mar 30, 2004
Ascorbic acid analogs for metalloradiopharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO35 citations93
US6869590B2Mar 22, 2005
Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
BRISTOL MYERS SQUIBB PHARMA CO19 citations92
US6416733B1Jul 9, 2002
Radiopharmaceuticals for imaging infection and inflammation
BRISTOL MYERS SQUIBB PHARMA CO56 citations92
US6932960B2Aug 23, 2005
N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
BRISTOL MYERS SQUIBB PHARMA CO15 citations84
US6517814B2Feb 11, 2003
Macrocyclic chelants useful for metallopharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO19 citations84
US6974567B2Dec 13, 2005
Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
BRISTOL MYERS SQUIBB PHARMA CO14 citations83
US6916460B2Jul 12, 2005
Macrocyclic chelants for metallopharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO10 citations74
US6685914B1Feb 3, 2004
Macrocyclic chelants for metallopharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO10 citations74
US6534038B2Mar 18, 2003
Ternary ligand complexes useful as radiopharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO12 citations74
ZENITH EPIGENETICS LTD
6 patentsUS9861637B2Jan 9, 2018
Heterocyclic compounds as bromodomain inhibitors
ZENITH EPIGENETICS LTD20 citations93
US9662311B2May 30, 2017
Substituted bicyclic compounds as bromodomain inhibitors
ZENITH EPIGENETICS LTD25 citations93
US10010556B2Jul 3, 2018
Bicyclic bromodomain inhibitors
ZENITH EPIGENETICS LTD4 citations83
US10363257B2Jul 30, 2019
Bicyclic bromodomain inhibitors
ZENITH EPIGENETICS LTD8 citations82
US10226451B2Mar 12, 2019
Substituted bicyclic compounds as bromodomain inhibitors
ZENITH EPIGENETICS LTD2 citations72
US10166215B2Jan 1, 2019
Substituted bicyclic compounds as bromodomain inhibitors
ZENITH EPIGENETICS LTD1 citations72
DU PONT MERCK PHARMA
3 patentsUS5750088AMay 12, 1998
Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
DU PONT MERCK PHARMA49 citations94
US5744120AApr 28, 1998
Ternary radiopharmaceutical complexes
DU PONT MERCK PHARMA40 citations92
US5879657AMar 9, 1999
Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
DU PONT MERCK PHARMA23 citations90
LIU SHUANG
3 patentsZENITH EPIGENETICS CORP
3 patentsUS9663520B2May 30, 2017
Bicyclic bromodomain inhibitors
ZENITH EPIGENETICS CORP16 citations91
US9636328B2May 2, 2017
Substituted bicyclic compounds as bromodomain inhibitors
ZENITH EPIGENETICS CORP19 citations91
US9598367B2Mar 21, 2017
Heterocyclic compounds as bromodomain inhibitors
ZENITH EPIGENETICS CORP15 citations82
DU PONT PHARM CO
2 patentsALBANY MOLECULAR RES INC
2 patentsUS9604960B2Mar 28, 2017
Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
ALBANY MOLECULAR RES INC28 citations93
US7956050B2Jun 7, 2011
Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ALBANY MOLECULAR RES INC13 citations81
BRISTOL MYERS SQUIBB CO
2 patentsFAIRFAX DAVID JOHN
2 patentsMOLINO BRUCE F
2 patentsUS8236796B2Aug 7, 2012
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
MOLINO BRUCE F10 citations83
US8227486B2Jul 24, 2012
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
MOLINO BRUCE F10 citations83
(unassigned)
2 patentsAIFI INC
2 patentsAMR TECHNOLOGY INC
1 patentPHARMACIA CORP
1 patentUNIV YANSHAN
1 patentQIU JUN
1 patentKNOPP BIOSCIENCES LLC
1 patentLOBBEN PAUL
1 patentCERTAINTEED LLC
1 patentAPPLE INC
1 patentYITUO ELECTRIC CO LTD
1 patentShowing the top 50 of 140 patents by PatentIndex Score.